GDPGP1
Basic information
Region (hg38): 15:90233808-90245811
Previous symbols: [ "C15orf58" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GDPGP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 41 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 41 | 2 | 0 |
Variants in GDPGP1
This is a list of pathogenic ClinVar variants found in the GDPGP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-90233828-C-G | Likely benign (Aug 04, 2023) | |||
15-90233841-C-T | Likely benign (Dec 15, 2023) | |||
15-90233847-C-A | Likely benign (Mar 04, 2022) | |||
15-90233853-C-G | Uncertain significance (Aug 05, 2022) | |||
15-90233866-C-A | Uncertain significance (Aug 21, 2022) | |||
15-90233867-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
15-90233873-C-T | Uncertain significance (Aug 22, 2021) | |||
15-90233877-G-A | Likely benign (May 23, 2024) | |||
15-90233877-GC-G | Pathogenic (Jun 24, 2024) | |||
15-90233877-GCC-G | Epidermodysplasia verruciformis, susceptibility to, 3 | Likely pathogenic (Feb 02, 2023) | ||
15-90233878-C-T | Uncertain significance (Nov 25, 2020) | |||
15-90233880-C-T | Likely benign (Oct 22, 2023) | |||
15-90233885-TC-AA | Uncertain significance (Apr 08, 2022) | |||
15-90234035-G-A | not specified | Benign (Jan 24, 2024) | ||
15-90240916-T-G | not specified | Uncertain significance (Feb 21, 2024) | ||
15-90240945-T-G | not specified | Uncertain significance (Oct 20, 2021) | ||
15-90240961-A-G | not specified | Uncertain significance (Nov 09, 2023) | ||
15-90240973-G-A | not specified | Likely benign (Feb 24, 2025) | ||
15-90241026-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
15-90241048-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
15-90241137-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
15-90241149-C-G | not specified | Likely benign (Oct 09, 2024) | ||
15-90241150-G-T | not specified | Uncertain significance (Oct 04, 2024) | ||
15-90241177-G-A | not specified | Uncertain significance (Dec 20, 2022) | ||
15-90241191-G-A | not specified | Uncertain significance (Feb 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GDPGP1 | protein_coding | protein_coding | ENST00000558017 | 1 | 8276 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.19e-8 | 0.0560 | 125670 | 0 | 78 | 125748 | 0.000310 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.177 | 221 | 229 | 0.967 | 0.0000141 | 2458 |
Missense in Polyphen | 87 | 93.841 | 0.9271 | 1022 | ||
Synonymous | -0.881 | 109 | 97.9 | 1.11 | 0.00000563 | 872 |
Loss of Function | -0.625 | 11 | 8.98 | 1.23 | 4.73e-7 | 94 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00226 | 0.00226 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000246 | 0.000246 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Specific and highly efficient GDP-D-glucose phosphorylase regulating the levels of GDP-D-glucose in cells. {ECO:0000269|PubMed:21507950}.;
Intolerance Scores
- loftool
- rvis_EVS
- 0.84
- rvis_percentile_EVS
- 88.38
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.451
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gdpgp1
- Phenotype
Gene ontology
- Biological process
- glucose metabolic process
- Cellular component
- cytoplasm
- Molecular function
- nucleotide binding;guanyl-nucleotide exchange factor activity;nucleotidyltransferase activity;hydrolase activity;GDP-D-glucose phosphorylase activity